(+)-DHMEQ

(+)-DHMEQ

(+)-DHMEQ is an activator of antioxidant transcription factor Nrf2. (+)-DHMEQ is the enantiomer of (-)-DHMEQ. (-)-DHMEQ inhibits NF-kB than its enantiomer (+)-DHMEQ. IC50 & Target: Nrf2[1] In Vitro: (+)-DHMEQ ((2R,3R,4R)-DHMEQ) activates Nrf2, which is a transcription factor that induces the expression of multiple antioxidant enzymes. (+)-DHMEQ activates Nrf2 in a promoter reporter assay. (+)-DHMEQ also increases the expression of target antioxidant proteins and cancelled reactive oxygen species (ROS)-induced cell death in a neuronal cell line. ROS generating 6-hydroxydopamine hydrochloride (6-OHDA) induces the death of SK-N-SH cells, and (+)-DHMEQ decreases the cytotoxic effect of 6-OHDA, whereas its effect is weaker in Nrf2-knockdown cells prepared with siRNA. Thus, enhancement of the neural cell viability by (+)-DHMEQ is due to the activation of Nrf2[1].
Cat# Size Price Qty Buy
CS-5817-25mg 25mg
£720.00
CS-5817-10mg 10mg
£360.00
CS-5817-5mg 5mg
£264.00
CS-5817-2mg 2mg
£168.00

Additional Information

Property Value or Rating
Manufacturer ChemScene LLC
Manufacturer Cat# CS-5817
Pathway NF-κB
Target Keap1-Nrf2

Related Documents